For GDF2, the known genetic pediatric PAH cases to date constitute one homozygous missense variant carrier and a compound heterozygote with a missense variant on one allele and a large deletion encompassing GDF2 and BMP10 on the second chromosome (Gallego et al., 2021; Wang et al., 2016). Here, GDF2 is linked to pulmonary arterial hypertension.